Key Highlights
- Mirador Therapeutics names Gregg Gilbert as new CFO
- Gregg brings over 25 years of biopharma equity research and investment banking experience
- Previously served as Managing Director at Bank of America Securities
- Focused on advancing Mirador’s precision therapies for immunology and inflammation
- Mirador raised over $400 million since its launch in 2024
Source: Business Wire
Notable Quotes
- “We are thrilled to welcome Gregg at this critical point in our company’s trajectory. Gregg’s impressive Wall Street experience bridges corporate and investor perspectives, and will be invaluable to guiding our next phase of growth.” — Mark C. McKenna, Chairman and CEO at Mirador Therapeutics
- “I am humbled to join this exceptionally talented and collaborative team as CFO, and look forward to making a meaningful impact as we work to deliver the next wave of precision medicines in I&I.” — Gregg Gilbert, CFO at Mirador Therapeutics
SoHC's Take
The appointment of Gregg Gilbert as CFO at Mirador Therapeutics signifies a strategic move to enhance its financial operations and investor relations as the company accelerates the development of next-generation precision therapies for immunology and inflammation. With over 25 years of experience advising biopharma companies and guiding capital strategies, Gregg’s leadership will be pivotal as Mirador transitions into its next growth phase. This appointment aligns with Mirador’s broader goal of rapidly building a diversified portfolio of transformational therapies.
Heading
Key Highlights Shore Capital Partners launches Agentis Longevity to lead the longevity healthcare sector. Jimmy St Louis named CEO, bringing expertise from Regenerative Medicine ...
Key Highlights Nymbl Systems announces strategic partnership with Frontier Growth to accelerate growth and innovation. Frontier Growth brings 25+ years of growth equity expertise to ...
Key Highlights Launch of fingertip blood collection technology using BD’s MiniDraw™ and Babson’s BetterWay for U.S. health systems. Revolutionizes access with fewer ...
Key Highlights Anatomy Financial raises $19M in Series A funding, led by Canapi Ventures. Neil Underwood (Canapi) and Nicole Quinn ...
Key Highlights Wendy Barnes to assume role as GoodRx CEO on January 1, 2025. Brings 30+ years of leadership in pharmacy and healthcare benefit industries. Former CEO of RxBenefits and President of Express ...
Key Highlights Mike Butler, former Providence president, joins Linus Health's board of directors. Butler brings decades of healthcare leadership and ...
